FDA Adverse Event Malfunction Summary report: N

RUBY COIL

MDR report key: 9767080 · Received February 27, 2020

Report

Report Number
3005168196-2020-00261
Event Type
Malfunction
Date Received
February 27, 2020
Date of Event
February 7, 2020
Report Date
February 7, 2020
Manufacturer
PENUMBRA, INC.
Product Code
HCG
UDI-DI
00814548018553
PMA / PMN Number
K173614
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

PLEASE NOTE THAT THE FOLLOWING SECTIONS WERE INCORRECTLY REPORTED ON THE INITIAL MFR REPORT AND ARE BEING CORRECTED ON THIS FOLLOW-UP #01 MFR REPORT: 3005168196-2020-00261. 1. SECTION A. BOX 4. LBS/KGS.

Description of Event or Problem · 0

THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE GASTRODUODENAL ARTERY (GDA) USING A RUBY COIL AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, WHILE ADVANCING THE RUBY COIL INTO THE MICROCATHETER, THE PUSHER WIRE BECAME KINKED; THEREFORE, THE RUBY COIL WAS REMOVED. THE PROCEDURE WAS COMPLETED USING A NEW RUBY COIL AND THE SAME MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

Additional Manufacturer Narrative · 1

THE PRODUCT WAS NOT RETURNED FOR EVALUATION. WITHOUT THE RETURN OF THE DEVICE, THE ROOT CAUSE OF THE PROBLEM CANNOT BE DETERMINED. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS.

Description of Event or Problem · 1

THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE GASTRODUODENAL ARTERY (GDA) USING A RUBY COIL AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, WHILE ADVANCING THE RUBY COIL INTO THE MICROCATHETER, THE PUSHER WIRE BECAME KINKED; THEREFORE, THE RUBY COIL WAS REMOVED. THE PROCEDURE WAS COMPLETED USING A NEW COIL. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
228913 RUBY COIL HCG, KRD HCG PENUMBRA, INC. RBY2C0312-B F94484 00814548018553

Patients

Seq Age Sex Outcome Treatment
1 49 YR